PHARMACIA & UPJOHN CO LTD has a total of 46 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Republic of Korea, Australia and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are BAETTIG URS, NEUROTHERAPEUTICS PHARMA INC and SHANGHAI INST MATERIA MEDICA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 29 | |
#2 | Australia | 5 | |
#3 | China | 5 | |
#4 | Canada | 2 | |
#5 | United States | 2 | |
#6 | Colombia | 1 | |
#7 | Israel | 1 | |
#8 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Jagodzinska Barbara | 3 |
#2 | John Varghese | 3 |
#3 | Cebula Mateusz | 3 |
#4 | Henegar Kevin Edward | 3 |
#5 | Britten Nancy Jean | 3 |
#6 | Waldron Niki Ann | 3 |
#7 | Groppi Vincent Edward Jr | 2 |
#8 | Burns John William Ii | 2 |
#9 | Ellsworth Michael Aaron | 2 |
#10 | Vonderwell Brenda Sue | 2 |
Publication | Filing date | Title |
---|---|---|
CN101155805A | 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents | |
CN101155806A | Oxindole oxazolidinone as antibacterial agent | |
KR20070042567A | Glycerol branched polyethylene glycol human growth hormone conjugates, process for their preparation, and methods of use thereof | |
CN101031318A | Cellular permissivity factor for viruses and uses thereof | |
CN1829510A | Dispersible formulation of an anti-inflammatory agent | |
KR20050044533A | (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease | |
AU2001253113B2 | Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis | |
RU2205832C2 | S-oxido- and s,s-dioxidotetrahydrothiopyrane phenyloxazolidinones and method for their testing |